Clinical Trial Update: Capstan Medical TMVR Study: FIH [NA]

View source ↗

Summary

Capstan Medical's first-in-human transcatheter mitral valve replacement study for mitral regurgitation is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Regurgitation

Snippet

Sponsor: Capstan Medical | Conditions: Mitral Regurgitation | NA | Status: RECRUITING